JPWO2023039472A5 - - Google Patents
Info
- Publication number
- JPWO2023039472A5 JPWO2023039472A5 JP2024515064A JP2024515064A JPWO2023039472A5 JP WO2023039472 A5 JPWO2023039472 A5 JP WO2023039472A5 JP 2024515064 A JP2024515064 A JP 2024515064A JP 2024515064 A JP2024515064 A JP 2024515064A JP WO2023039472 A5 JPWO2023039472 A5 JP WO2023039472A5
- Authority
- JP
- Japan
- Prior art keywords
- modification comprises
- modification
- nucleic acid
- mutant polypeptide
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163241821P | 2021-09-08 | 2021-09-08 | |
| US63/241,821 | 2021-09-08 | ||
| US202263296741P | 2022-01-05 | 2022-01-05 | |
| US63/296,741 | 2022-01-05 | ||
| PCT/US2022/076112 WO2023039472A2 (en) | 2021-09-08 | 2022-09-08 | Compositions comprising a crispr nuclease and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024531607A JP2024531607A (ja) | 2024-08-29 |
| JP2024531607A5 JP2024531607A5 (https=) | 2025-09-16 |
| JPWO2023039472A5 true JPWO2023039472A5 (https=) | 2025-09-16 |
Family
ID=85506919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515064A Pending JP2024531607A (ja) | 2021-09-08 | 2022-09-08 | Ｃｒｉｓｐｒヌクレアーゼを含む組成物及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12344870B2 (https=) |
| EP (1) | EP4399310A4 (https=) |
| JP (1) | JP2024531607A (https=) |
| AU (1) | AU2022344256A1 (https=) |
| CA (1) | CA3230609A1 (https=) |
| TW (1) | TW202321447A (https=) |
| WO (1) | WO2023039472A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3230609A1 (en) | 2021-09-08 | 2023-03-16 | Shaorong Chong | Compositions comprising a crispr nuclease and uses thereof |
| WO2024173645A1 (en) | 2023-02-15 | 2024-08-22 | Arbor Biotechnologies, Inc. | Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript |
| WO2025171210A1 (en) | 2024-02-09 | 2025-08-14 | Arbor Biotechnologies, Inc. | Compositions and methods for gene editing via homology-mediated end joining |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3241902B1 (en) | 2012-05-25 | 2018-02-28 | The Regents of The University of California | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
| US12431216B2 (en) | 2016-08-17 | 2025-09-30 | Broad Institute, Inc. | Methods for identifying class 2 crispr-cas systems |
| PL3765615T3 (pl) * | 2018-03-14 | 2023-11-13 | Arbor Biotechnologies, Inc. | Nowe enzymy i układy crispr ukierunkowane na dna |
| US12553045B2 (en) | 2018-07-16 | 2026-02-17 | Arbor Biotechnologies, Inc. | Crispr DNA targeting enzymes and systems |
| US20220049273A1 (en) | 2019-03-01 | 2022-02-17 | Arbor Biotechnologies, Inc. | Novel crispr dna targeting enzymes and systems |
| BR112022007125A2 (pt) * | 2019-10-17 | 2022-07-05 | Pairwise Plants Services Inc | Variantes de nucleases cas12a e métodos de produção e uso das mesmas |
| CN115052986A (zh) * | 2019-12-04 | 2022-09-13 | 阿伯生物技术公司 | 包含核酸酶的组合物及其用途 |
| CA3230609A1 (en) | 2021-09-08 | 2023-03-16 | Shaorong Chong | Compositions comprising a crispr nuclease and uses thereof |
-
2022
- 2022-09-08 CA CA3230609A patent/CA3230609A1/en active Pending
- 2022-09-08 EP EP22868305.8A patent/EP4399310A4/en active Pending
- 2022-09-08 TW TW111134168A patent/TW202321447A/zh unknown
- 2022-09-08 US US17/930,595 patent/US12344870B2/en active Active
- 2022-09-08 JP JP2024515064A patent/JP2024531607A/ja active Pending
- 2022-09-08 WO PCT/US2022/076112 patent/WO2023039472A2/en not_active Ceased
- 2022-09-08 AU AU2022344256A patent/AU2022344256A1/en active Pending
-
2025
- 2025-05-30 US US19/223,291 patent/US20250290053A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7700079B2 (ja) | ゲノム編集のためのシステム及び方法 | |
| CN113373130A (zh) | Cas12蛋白、含有Cas12蛋白的基因编辑系统及应用 | |
| JP2025161809A5 (https=) | ||
| KR20240055073A (ko) | 클래스 ii, v형 crispr 시스템 | |
| WO2019161290A1 (en) | Engineered cas9 systems for eukaryotic genome modification | |
| CN107794272A (zh) | 一种高特异性的crispr基因组编辑体系 | |
| AU2021358805A1 (en) | Engineered guide RNA for optimized CRISPR/Cas12f1 (Cas14a1) system and use thereof | |
| US12435323B2 (en) | Enzymes with RUVC domains | |
| JPWO2021202800A5 (https=) | ||
| JP2024073630A (ja) | 新規転写アクチベーター | |
| JPWO2023039472A5 (https=) | ||
| KR20180128864A (ko) | 매칭된 5' 뉴클레오타이드를 포함하는 가이드 rna를 포함하는 유전자 교정용 조성물 및 이를 이용한 유전자 교정 방법 | |
| CN106459940B (zh) | 新型过氧化氢酶信号序列及利用其的过氧化氢酶表达方法 | |
| CN120092083A (zh) | 包含Cas蛋白和细菌毒素的融合蛋白及其用途 | |
| CN113652411A (zh) | Cas9蛋白、含有Cas9蛋白的基因编辑系统及应用 | |
| WO2026067648A1 (en) | Type ii cas protein and uses thereof | |
| KR102935503B1 (ko) | 신규 Cas12a 단백질, 신규 Cas12a 단백질의 변형체 및 이들의 진핵세포 유전체 편집 용도 | |
| RU2800921C2 (ru) | Новый активатор транскрипции | |
| CN121780484A (zh) | CRISPR-Cas12b2基因编辑系统及其应用 | |
| KR20250140037A (ko) | 박테리아 톡신 변이체 및 이의 용도 | |
| CN116568806A (zh) | 用于增加crispr/cas12f1（cas14a1）系统的效率的经工程化的引导rna及其用途 | |
| CN119082083A (zh) | 人源化CRISPRa系统及其应用 | |
| CN116926039A (zh) | 反转录酶HIV p66突变体及其应用 | |
| CN121825935A (zh) | Hsp8Cas9或其突变体、含有Hsp8Cas9或其突变体的基因编辑系统及应用 | |
| HK1261024A1 (en) | System and method for genome editing |